Biocompatible synthesis of reduced graphene oxide from Euphorbia heterophylla (L.) and their in-vitro cytotoxicity against human cancer cell lines

[Display omitted] •A simple and facile biocompatible method for the reduction of graphene oxide (GO).•Reduction of graphene oxide (rGO) from leaves extract of Euphorbia heterophylla (L.).•The rGO shows significant cytotoxicity on A549- Human Lung Cancer cell line and HepG2-Human Hepatocarcinomatous...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biotechnology reports (Amsterdam, Netherlands) Netherlands), 2019-12, Vol.24, p.e00376-e00376, Article e00376
Hauptverfasser: Lingaraju, K., Raja Naika, H., Nagaraju, G., Nagabhushana, H.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:[Display omitted] •A simple and facile biocompatible method for the reduction of graphene oxide (GO).•Reduction of graphene oxide (rGO) from leaves extract of Euphorbia heterophylla (L.).•The rGO shows significant cytotoxicity on A549- Human Lung Cancer cell line and HepG2-Human Hepatocarcinomatous Cell lines.•Green synthesis of rGO is very easy, in expensive, cheap, non-toxic, biocompatibility and ecofriendly. Facile and biocompatible synthesis of reduced graphene oxide from graphene oxide as a precursor and aqueous leaves extract of Euphorbia heterophylla (L.), act as a reducing /capping /stabilizing agent by green chemistry approaches. The obtained product was analyzed by Ultraviolet-Visible spectroscopy (UV–vis), X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FT-IR), Raman spectroscopy and Scanning electron Microscopy (SEM). In addition to this, the significant cytotoxicity of rGO studied against cancerous cell lines such as A549- Human Lung cancer cell line and HepG2-Human Hepatocarcinoma Cell lines in-vitro. These results indicate that the biocompatible synthesis of rGO is straightforward, inexpensive and environmentally friendly for promising large-scale production of industrial purpose and then finding further biomedical applications.
ISSN:2215-017X
2215-017X
DOI:10.1016/j.btre.2019.e00376